[PDF][PDF] The donor risk index: a decade of experience
A Flores, SK Asrani - Liver Transplantation, 2017 - Wiley Online Library
In 2006, derivation of the donor risk index (DRI) highlighted the importance of donor factors
for successful liver transplantation. Over the last decade, the DRI has served as a useful …
for successful liver transplantation. Over the last decade, the DRI has served as a useful …
[PDF][PDF] Current status of simultaneous liver‐kidney transplantation in the United States
EL Lum, A Cárdenas, P Martin… - Liver …, 2019 - Wiley Online Library
On August 10, 2017, a formal policy was enacted in the United States that defined listing
criteria for simultaneous liver‐kidney transplantation and priority for patients who received a …
criteria for simultaneous liver‐kidney transplantation and priority for patients who received a …
Simultaneous liver kidney allocation policy and the Safety Net: an early examination of utilization and outcomes in the United States
PJ Altshuler, AP Shah, AM Frank… - Transplant …, 2021 - Wiley Online Library
Rates of simultaneous liver kidney (SLK) transplantation in the United States have
progressively risen. On 8/10/17, the Organ Procurement and Transplantation Network …
progressively risen. On 8/10/17, the Organ Procurement and Transplantation Network …
Differential in Kidney Graft Years Based on Solitary Kidney, Simultaneous Liver-Kidney, and Kidney after Liver Transplants
Background The number of simultaneous liver-kidney transplants has significantly increased
in the United States. There has also been an increase in kidney-after-liver transplants …
in the United States. There has also been an increase in kidney-after-liver transplants …
[HTML][HTML] Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges
The population of patients with hepatocellular carcinoma (HCC) overlaps to a high degree
with those for chronic kidney disease (CKD) and end-stage renal disease (ESRD). The …
with those for chronic kidney disease (CKD) and end-stage renal disease (ESRD). The …
Impact of sarcopenia on clinical outcomes of patients undergoing simultaneous liver and kidney transplantation: a cohort study
A Mazzola, R Brustia, B Magro, M Atif, N Ouali… - Clinics and Research in …, 2021 - Elsevier
Background The impact of sarcopenia in patients undergoing simultaneous liver and kidney
transplantation (SLKT) has not been fully delineated. The aim of this single-centre-cohort …
transplantation (SLKT) has not been fully delineated. The aim of this single-centre-cohort …
[PDF][PDF] Excellent outcomes in combined liver‐kidney transplantation: impact of kidney donor profile index and delayed kidney transplantation
The positive impact of delayed kidney transplantation (KT) on patient survival for combined
liver‐kidney transplantation (CLKT) has already been demonstrated by our group. The …
liver‐kidney transplantation (CLKT) has already been demonstrated by our group. The …
[PDF][PDF] Lack of benefit and potential harm of induction therapy in simultaneous liver‐kidney transplants
N AbdulRahim, L Anderson, S Kotla, H Liu… - Liver …, 2019 - Wiley Online Library
The number of simultaneous liver‐kidney transplantations (SLKTs) and use of induction
therapy for SLKT have increased recently, without much published evidence, especially in …
therapy for SLKT have increased recently, without much published evidence, especially in …
Current state of multiorgan transplantation and implications for future practice and policy
SG Westphal, ED Langewisch, CD Miles - Advances in Chronic Kidney …, 2021 - Elsevier
The incidence of kidney dysfunction has increased in liver transplant and heart transplant
candidates, reflecting a changing patient population and allocation policies that prioritize the …
candidates, reflecting a changing patient population and allocation policies that prioritize the …
Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver–kidney transplant recipients
Abstract Background De novo Donor Specific Antibodies (DSA) are considered as a risk
factor for the kidney allograft outcomes in recipients after simultaneous liver–kidney …
factor for the kidney allograft outcomes in recipients after simultaneous liver–kidney …